It is unsafe to consume alcohol with Solrin 75.
CONSULT YOUR DOCTOR
Solrin 75 is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
CONSULT YOUR DOCTOR
Solrin 75 is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Solrin 75 may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Solrin 75 should be used with caution in patients with kidney disease. Dose adjustment of Solrin 75 may be needed. Please consult your doctor. Use of Solrin 75 is not recommended in patients with severe kidney disease.
Solrin 75 should be used with caution in patients with liver disease. Dose adjustment of Solrin 75 may be needed. Please consult your doctor. Use of Solrin 75 is not recommended in patients with severe liver disease.
Solrin 75 is an antiplatelet medicine used to treat and prevent heart attacks, strokes and heart-related chest pain (angina). It helps to prevent the formation of blood clots in your blood vessels. It is a very widely used medicine for heart protection. Solrin 75 is usually best taken with food otherwise it may upset your stomach. The dose that is right for you depends on what you are taking it for and how well it helps your symptoms. You should take it as recommended by your doctor. The most common side effects of this medicine are heartburn or upset stomach, nausea, and vomiting. These are not usually serious but if you are worried, ask your doctor about ways of reducing or preventing them. This medicine may sometimes cause you to bleed more easily (for example you may get nosebleeds or bruises). Before taking it, you should let your doctor know if you have ever had a prolonged problem when your blood did not clot properly or if you have had an ulcer or bleeding in your stomach or intestine. To make sure this medicine is safe for you, also tell your doctor if you have trouble with your liver or kidneys, have high blood pressure or asthma. Let your doctor know about all the other medicines you are taking because they may affect, or be affected by, this medicine. Pregnant or breastfeeding women should consult their doctor before starting treatment. It is usually not recommended in later stages of pregnancy and while breastfeeding. Avoid drinking alcohol while you are taking this medicine. Heavy drinking can increase your risk of stomach bleeding.
Uses of Solrin 75
- Heart attack
- Angina (heart-related chest pain)
Side effects of Solrin 75
- Increased bleeding tendency
- Upset stomach
How to use Solrin 75
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Solrin 75 is to be taken with food.
How Solrin 75 works
Solrin 75 is a non-steroidal anti-inflammatory drug (NSAID) with anti-platelet action. It works by preventing platelets from sticking together which decreases the formation of harmful blood clots. This lowers the chance of heart attack or stroke.
- Solrin 75 helps prevent future heart attack and clot-related (ischemic) stroke.
- It is generally well-tolerated with minimum side effects.
- Take it with food to avoid an upset stomach.
- It may make you bleed more easily. Be careful while shaving, using sharp objects, or cutting fingernails or toenails.
- Inform your doctor if you notice blood in your vomit or have black/tarry stools.
- Stop taking Solrin 75 and tell your doctor if you have ringing in your ears, unusual bleeding, or nausea or vomiting that does not go away.
PO Prophylaxis of myocardial infarction Adult: 75-300 mg once daily. Lower doses should be used in patients receiving ACE inhibitors. Stent implantation Adult: 300 mg 2 hr before procedure followed by 150-300 mg/day thereafter. Mild to moderate pain and fever Adult: 150-300 mg repeated every 4-6 hr according to response. Max: 4 g/day. Pain and inflammation associated with musculoskeletal and joint disorders Adult: Initial: 2.4-3.6 g/day in divided doses. Usual maintenance: 3.6-5.4 g/day. Monitor serum concentrations. Hepatic impairment: Severe liver disease: Not recommended
Alcohol, corticosteroids, analgin, phenylbutazone and oxyphenbutazone may increase risk of GI ulceration. Aspirin increases phenytoin levels. May antagonize actions of uricosurics and spironolactone. Potentially Fatal: May potentiate effects of anticoagulants, methotrexate and oral hypoglycaemics.
Patients with history of asthma, angioedema, urticaria or rhinitis, nasal polyp, severe renal or hepatic impairment, lactation. Lactation: Drug enters breast milk; decision should be made regarding whether to discontinue nursing or to discontinue drug, taking into account importance of drug to mother.
Pregnancy category: C; D in 3rd trimester
Aspirin is an analgesic, anti-inflammatory and antipyretic. It inhibits cyclooxygenase, which is responsible for the synthesis of prostaglandin and thromboxane. It also inhibits platelet aggregation.
PO Juvenile rheumatoid arthritis Child: <25 kg: 60-100 mg/kg/day PO divided q6-8hr (maintain serum salicylate at 150-300 mcg/mL) >25 kg: 2.4-3.6 g/day Pain & Fever <12 years 10-15 mg/kg PO q4hr, up to 60-80 mg/kg/day
Mode of Action
Should be taken with food.
Fever, Headache, Pain/inflammation, Acute coronary syndrome, TIA, MI, Stroke
Renal impairment CrCl >10 mL/min: Dose adjustment not necessary CrCl <10 mL/min: Not recommended
Pregnancy Category Note
GI disturbances; prolonged bleeding time, rhinitis, urticaria and epigastric discomfort; angioedema, salicylism, tinnitus; bronchospasm. Potentially Fatal: Gastric erosion, ulceration and bleeding; severe, occasionally fatal exacerbation of airway obstruction in asthma; Reye's syndrome (children <12 yr). Hepatotoxicity; CNS depression which may lead to coma; CV collapse and resp failure; paroxysmal bronchospasm and dyspnoea.
Hypersensitivity (attacks of asthma, angioedema, urticaria or rhinitis), active peptic ulceration; pregnancy (3rd trimester), children <12 yr, patients with haemophilia or haemorrhagic disorders, gout, severe renal or hepatic impairment, lactation.
The information provided herein is accurate, updated and complete as per the best practices of the Company. Please note that this information should not be treated as a replacement for physical medical consultation or advice. We do not guarantee the accuracy and the completeness of the information so provided. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company. We do not take any responsibility for the consequences arising out of the aforementioned information and strongly recommend you for a physical consultation in case of any queries or doubts.